Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions

Penson, Peter E., Mancini, G. B. John, Toth, Peter P., Martin, Seth S., Watts, Gerald F., Sahebkar, Amirhossein, Mikhailidis, Dimitri P., Banach, Maciej, on behalf of Lipid and Blood Pressure Meta‐Analysis Collaboration (LBPMC) Group & International Lipid Expert Panel (ILEP)·2018·Journal of Cachexia, Sarcopenia and Muscle
DOI 10.1002/jcsm.12344

Cited by (110)

Items 101–110 of 110

  1. Conclusions and Future Directions
    Beth A. Taylor, Paul D. Thompson · 2020 · Contemporary cardiology
  2. Statin uses and skeletal muscle-related phenotypes: insights from epidemiological and Mendelian randomization analyses
    Fan Tang, Zhanchao Chen, Hongbin Qiu, Yige Liu, Yanjiao Shen, Yiying Zhang, Shanjie Wang, Bo Yu · 2024 · medRxiv
  3. Breaking the cycle: Addressing the drucebo effect in lymphedema care
    Roberto Tedeschi · 2025 · Phlebology The Journal of Venous Disease
  4. The Drucebo effect in occupational therapy: A double-edged phenomenon
    Roberto Tedeschi · 2025 · British Journal of Occupational Therapy
  5. Additional file 1 of Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
    Morieri, Mario Luca, Olga Lamacchia, Enzo Manzato, Andrea Giaccari, Angelo Avogaro · 2022 · Figshare
  6. Predictors of statin intolerance among statin users in primary care using real-world data
    Shagoofa Rakhshanda, Siaw‐Teng Liaw, Joel Rhee, Kerry‐Anne Rye, Jitendra Jonnagaddala · 2026 · medRxiv
  7. Interventions to manage intolerance among patients prescribed statins for primary prevention of cardiovascular diseases: A systematic review and meta-analysis
    Shagoofa Rakhshanda, Joel Rhee, Siaw‐Teng Liaw, Kerry‐Anne Rye, Jitendra Jonnagaddala · 2026 · medRxiv
  8. Nocebo effects in long-term health conditions: a systematic review of experimental studies
    B Church, Pankaj Gupta, Adarsh Shivaram, Sian Jenkins, Emma J. Palmer · 2026 · Frontiers in Psychiatry
  9. Bempedoic acid in a high-risk primary-prevention patient unable to take statins: a case-based approach
    Natalia Barańska, Jakub Michał Zimodro, Renata Główczyńska, Marcin Grabowski, Joanna K. Rogozik · 2026 · Archives of Medical Science
  10. A novel provocation protocol to identify nocebo effects in clinical practice—a proof-of-concept n-of-1 study
    Martin Coenen, Gunther Hartmann, Thomas Büttner · 2026 · Frontiers in Pharmacology